Table S6 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents
Year: 2023
Type: other
Abstract: Gene expression data after TK-216 treatment (8h) in U2932. A) Supervised analysis of transcriptome after treatment B) Gene-sets significantly enriched after treatment. C) IRF4/SPIB and lenalidomide related gene-sets significantly enriched after treatment.
Authors: Filippo Spriano, Elaine Yee Lin Chung, Eugenio Gaudio, Chiara Tarantelli, Luciano Cascione, Sara Napoli, Katti Jessen, Laura Carrassa, Valdemar Priebe, Giulio Sartori, Garrett Graham, Saravana P. Selvanathan, Andrea Cavalli, Andrea Rinaldi, Ivo Kwee, Monica Testoni, Davide Genini, B. Hilda Ye, Emanuele Zucca, Anastasios Stathis, Brian Lannutti, Jeffrey A. Toretsky, Francesco Bertoni
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361887850
